We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Celldex Therapeutics Announces Initiation of Phase 1 Clinical Trial of CDX-301

News   Jan 17, 2012

 
Celldex Therapeutics Announces Initiation of Phase 1 Clinical Trial of CDX-301
 
 
Advertisement
 

RELATED ARTICLES

Training Neural Circuits-in-a-Dish Early Makes for Sharper Responses

News

When it comes to training neural circuits for tissue engineering or biomedical applications, a new study suggests a key parameter: Train them young.

READ MORE

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

New Insights Into How Ovarian Cancer Grows and Evolves

News

In a paper published in the journal Cancer Research, researchers provide new insights into how ovarian cancer grows and evolves within a person.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE